This post was originally published on this site
Intuitive Surgical (NASDAQ:ISRG) shares gained more than 7% after-hours following the company’s reported Q3 results, with EPS of $1.19 coming in better than the consensus estimate of $1.12. Revenue grew 11% year-over-year (up 15% on a constant currency basis) to $1.56 billion, beating the consensus estimate of $1.51 billion, driven by growth in da Vinci procedure volume, partially offset by a decline in system placements.
Q3 instruments and accessories revenue grew 15% to $872 million, compared to $755 million in Q3/21, primarily driven by approximately 20% growth in da Vinci procedure volume, partially offset by foreign currency impacts and customer buying patterns.
